Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC29709133;9134;9135 chr2:178768928;178768927;178768926chr2:179633655;179633654;179633653
N2AB29709133;9134;9135 chr2:178768928;178768927;178768926chr2:179633655;179633654;179633653
N2A29709133;9134;9135 chr2:178768928;178768927;178768926chr2:179633655;179633654;179633653
N2B29248995;8996;8997 chr2:178768928;178768927;178768926chr2:179633655;179633654;179633653
Novex-129248995;8996;8997 chr2:178768928;178768927;178768926chr2:179633655;179633654;179633653
Novex-229248995;8996;8997 chr2:178768928;178768927;178768926chr2:179633655;179633654;179633653
Novex-329709133;9134;9135 chr2:178768928;178768927;178768926chr2:179633655;179633654;179633653

Information

  • RefSeq wild type amino acid: M
  • RefSeq wild type transcript codon: ATG
  • RefSeq wild type template codon: TAC
  • Domain: Ig-20
  • Domain position: 2
  • Structural Position: 2
  • Q(SASA): 0.403
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
M/I None None 0.019 N 0.265 0.133 0.414281671643 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0
M/T None None 0.175 N 0.38 0.33 None gnomAD-4.0.0 1.59137E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85664E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
M/A 0.3524 ambiguous 0.4455 ambiguous -0.83 Destabilizing 0.104 N 0.396 neutral None None None None N
M/C 0.7452 likely_pathogenic 0.8137 pathogenic -0.794 Destabilizing 0.859 D 0.383 neutral None None None None N
M/D 0.8164 likely_pathogenic 0.876 pathogenic -0.027 Destabilizing 0.859 D 0.413 neutral None None None None N
M/E 0.4574 ambiguous 0.5223 ambiguous -0.039 Destabilizing 0.364 N 0.413 neutral None None None None N
M/F 0.4268 ambiguous 0.5085 ambiguous -0.191 Destabilizing 0.124 N 0.252 neutral None None None None N
M/G 0.6881 likely_pathogenic 0.7713 pathogenic -1.056 Destabilizing 0.364 N 0.424 neutral None None None None N
M/H 0.4607 ambiguous 0.5401 ambiguous -0.098 Destabilizing 0.958 D 0.369 neutral None None None None N
M/I 0.3066 likely_benign 0.4249 ambiguous -0.301 Destabilizing 0.019 N 0.265 neutral N 0.413924349 None None N
M/K 0.1627 likely_benign 0.1978 benign -0.02 Destabilizing 0.301 N 0.378 neutral N 0.433170668 None None N
M/L 0.0957 likely_benign 0.1156 benign -0.301 Destabilizing None N 0.129 neutral N 0.381452771 None None N
M/N 0.455 ambiguous 0.567 pathogenic 0.037 Stabilizing 0.859 D 0.417 neutral None None None None N
M/P 0.9394 likely_pathogenic 0.9665 pathogenic -0.45 Destabilizing 0.859 D 0.419 neutral None None None None N
M/Q 0.2428 likely_benign 0.2621 benign -0.072 Destabilizing 0.859 D 0.344 neutral None None None None N
M/R 0.21 likely_benign 0.232 benign 0.513 Stabilizing 0.301 N 0.42 neutral N 0.484239506 None None N
M/S 0.4173 ambiguous 0.5119 ambiguous -0.447 Destabilizing 0.364 N 0.387 neutral None None None None N
M/T 0.1926 likely_benign 0.2425 benign -0.352 Destabilizing 0.175 N 0.38 neutral N 0.428088121 None None N
M/V 0.1021 likely_benign 0.1193 benign -0.45 Destabilizing 0.019 N 0.231 neutral N 0.44960014 None None N
M/W 0.7398 likely_pathogenic 0.8151 pathogenic -0.167 Destabilizing 0.958 D 0.377 neutral None None None None N
M/Y 0.6434 likely_pathogenic 0.7247 pathogenic -0.09 Destabilizing 0.667 D 0.428 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.